Modified conditioning regimen with idarubicin followed by autologous hematopoietic stem cell transplantation for invasive B-cell non-Hodgkin’s lymphoma patients

Modified conditioning regimen with idarubicin followed by autologous hematopoietic stem cell transplantation for invasive B-cell non-Hodgkin’s lymphoma patients

Abstract High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (ASCT) is still a consolidation treatment choice for relapsed/refractory B-cell non-Hodgkin’s lymphoma (NHL) patients and some aggressive B-cell NHL as frontline therapy. Due to the shortage of carmustine,...

Full description

Bibliographic Details
Main Authors: Chen Tian, Yueyang Li, Su Liu, Zehui Chen, Yizhuo Zhang, Yong Yu, Hongliang Yang, Haifeng Zhao, Zhigang Zhao, Tian Yuan, Yafei Wang
Format: Article
Language:English
Published: Nature Publishing Group 2021-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-81944-8

Internet

https://doi.org/10.1038/s41598-021-81944-8

Similar Items